These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26207697)

  • 41. Pathogenesis pathways of idiopathic pulmonary fibrosis in bleomycin-induced lung injury model in mice.
    Shi K; Jiang J; Ma T; Xie J; Duan L; Chen R; Song P; Yu Z; Liu C; Zhu Q; Zheng J
    Respir Physiol Neurobiol; 2014 Jan; 190():113-7. PubMed ID: 24140943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1.
    Kono Y; Nishiuma T; Nishimura Y; Kotani Y; Okada T; Nakamura S; Yokoyama M
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):395-404. PubMed ID: 17641298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. S14-Phosphorylated RPN6 Mediates Proteasome Activation by PKA and Alleviates Proteinopathy.
    Yang L; Parajuli N; Wu P; Liu J; Wang X
    Circ Res; 2023 Sep; 133(7):572-587. PubMed ID: 37641975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SENP1 regulates the transformation of lung resident mesenchymal stem cells and is associated with idiopathic pulmonary fibrosis progression.
    Sun W; Liu X; Yang X; Jing X; Duan C; Yang G; Wu C; Huang H; Luo Q; Xia S; Zhang Q; Yang Y; Xu Z
    Cell Commun Signal; 2022 Jul; 20(1):104. PubMed ID: 35836260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The mechanism of lung tissue remodeling in the progression of idiopathic pulmonary fibrosis].
    Kogan EA; Tyong FV; Demura SA
    Arkh Patol; 2010; 72(4):30-6. PubMed ID: 21086635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Tale of Two Proteolytic Machines: Matrix Metalloproteinases and the Ubiquitin-Proteasome System in Pulmonary Fibrosis.
    Roque W; Boni A; Martinez-Manzano J; Romero F
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and preclinical efficacy of novel transforming growth factor-β1 short interfering RNAs for pulmonary fibrosis.
    D'Alessandro-Gabazza CN; Kobayashi T; Boveda-Ruiz D; Takagi T; Toda M; Gil-Bernabe P; Miyake Y; Yasukawa A; Matsuda Y; Suzuki N; Saito H; Yano Y; Fukuda A; Hasegawa T; Toyobuku H; Rennard SI; Wagner PD; Morser J; Takei Y; Taguchi O; Gabazza EC
    Am J Respir Cell Mol Biol; 2012 Mar; 46(3):397-406. PubMed ID: 22033267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway.
    Inui N; Sakai S; Kitagawa M
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.
    Mizuno S; Matsumoto K; Li MY; Nakamura T
    FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. M2 macrophages promote myofibroblast differentiation of LR-MSCs and are associated with pulmonary fibrogenesis.
    Hou J; Shi J; Chen L; Lv Z; Chen X; Cao H; Xiang Z; Han X
    Cell Commun Signal; 2018 Nov; 16(1):89. PubMed ID: 30470231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ogerin mediated inhibition of TGF-β(1) induced myofibroblast differentiation is potentiated by acidic pH.
    Bell TJ; Nagel DJ; Woeller CF; Kottmann RM
    PLoS One; 2022; 17(7):e0271608. PubMed ID: 35901086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis.
    Lin C; Rezaee F; Waasdorp M; Shi K; van der Poll T; Borensztajn K; Spek CA
    Oncotarget; 2015 Nov; 6(34):35304-14. PubMed ID: 26474459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies.
    Tan J; Tedrow JR; Dutta JA; Juan-Guardela B; Nouraie M; Chu Y; Trejo Bittar H; Ramani K; Biswas PS; Veraldi KL; Kaminski N; Zhang Y; Kass DJ
    Am J Respir Crit Care Med; 2016 Dec; 194(11):1392-1402. PubMed ID: 27310652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FGF19 Is Downregulated in Idiopathic Pulmonary Fibrosis and Inhibits Lung Fibrosis in Mice.
    Justet A; Ghanem M; Boghanim T; Hachem M; Vasarmidi E; Jaillet M; Vadel A; Joannes A; Mordant P; Bonniaud P; Kolb M; Ling L; Cazes A; Mal H; Mailleux A; Crestani B
    Am J Respir Cell Mol Biol; 2022 Aug; 67(2):173-187. PubMed ID: 35549849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relaxin regulates myofibroblast contractility and protects against lung fibrosis.
    Huang X; Gai Y; Yang N; Lu B; Samuel CS; Thannickal VJ; Zhou Y
    Am J Pathol; 2011 Dec; 179(6):2751-65. PubMed ID: 21983071
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DACT2 protects against pulmonary fibrosis via suppressing glycolysis in lung myofibroblasts.
    Lai X; Huang S; Lin Y; Qiu Y; Pu L; Lin S; Zeng Q; Huang W; Wang Z
    Int J Biol Macromol; 2023 Jan; 226():291-300. PubMed ID: 36481337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wilms' tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease.
    Sontake V; Kasam RK; Sinner D; Korfhagen TR; Reddy GB; White ES; Jegga AG; Madala SK
    JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Novel Small Molecule BTB Inhibits Pro-Fibrotic Fibroblast Behavior though Inhibition of RhoA Activity.
    Rackow AR; Nagel DJ; Zapas G; Clough RS; Sime PJ; Kottmann RM
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteasomes in lungs from organ donors and patients with end-stage pulmonary diseases.
    Baker TA; Bach HH; Gamelli RL; Love RB; Majetschak M
    Physiol Res; 2014; 63(3):311-9. PubMed ID: 24564596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosis.
    Roach KM; Duffy SM; Coward W; Feghali-Bostwick C; Wulff H; Bradding P
    PLoS One; 2013; 8(12):e85244. PubMed ID: 24392001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.